NURUDEEN MAHAMA: Open Payments
NPI 1992782007 · YUMA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,869 in 46 payments from 14 companies in 2025. Trend: 2023 $719 · 2024 $646 · 2025 $2,869
Food & beverage: $1,690Travel & lodging: $1,179
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 10 | $1,478 |
| Ardelyx, Inc. | 5 | $267 |
| AKEBIA THERAPEUTICS INC | 2 | $247 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $143 |
| Travere Therapeutics, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 6 | $103 |
| Novartis Pharmaceuticals Corporation | 3 | $92 |
| Mallinckrodt Hospital Products Inc. | 1 | $70 |
| KYOWA KIRIN, INC. | 1 | $50 |
Products named: SYMPLICITY G3, Vafseo, XPHOZAH 30 MG, Kerendia, Filspari, Fabhalta, IBSRELA, ACTHAR.
Industry payments across AZ — which companies pay providers there.
